Given Shortages, Who ‘Deserves’ Ozempic and GLP-1 Drugs?
Drugmakers are struggling to keep up with the demand for weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). The limited supply is forcing doctors, public health experts, and insurers to confront an unpleasant question: …